quinazolines has been researched along with Depression in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, RK; Das, D; Gajbhiye, A; Mishra, S; Patil, S; Sahu, A; Verma, E | 1 |
| Li, JX; Seaman, RW; Shang, L; Siemian, JN; Zhang, Y; Zhu, Q | 1 |
| Alix, K; Argade, MD; De Felice, LJ; Dukat, M; Eltit, JM; Iyer, KA; Khatri, S; Pan, X; Schulte, MK; Solis, E; Sweet, DH | 1 |
| Lagos, P; Scorza, C; Torterolo, P; Urbanavicius, J | 1 |
| Buiting, HM; de Kanter, W; Linn, SC; Smorenburg, CH | 1 |
| Greer, J; Lynch, TJ; Pirl, WF; Sequist, L; Solis, J; Temel, JS | 1 |
| Frantz, S | 1 |
| Arunkalaivanan, A; Sinha, D | 1 |
| Chaki, S; Sekiguchi, Y; Semple, G; Thomsen, W; Tran, TA; Yamada, H; Yamaguchi, J | 1 |
| Bolzano, K | 1 |
2 review(s) available for quinazolines and Depression
| Article | Year |
|---|---|
[Living with incurable cancer].
Topics: Aged; Anxiety; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Depression; Emotions; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Prognosis; Psychotherapy; Quality of Life; Quinazolines | 2016 |
ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety.
Topics: Animals; Anxiety; Cyclohexylamines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Immobility Response, Tonic; Maze Learning; Motor Activity; Quinazolines; Receptors, Somatostatin | 2005 |
8 other study(ies) available for quinazolines and Depression
| Article | Year |
|---|---|
Electronegativity in Substituted-4(H)-quinazolinones Causes Anxiolysis without a Sedative-hypnotic Adverse Reaction in Female Wistar Rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Female; Hypnotics and Sedatives; Lethal Dose 50; Motor Activity; No-Observed-Adverse-Effect Level; Pentobarbital; Quinazolines; Rats; Rats, Wistar; Sleep; Swimming | 2020 |
Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats.
Topics: Analgesics; Animals; Benzofurans; Depression; Disease Models, Animal; Fibromyalgia; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Imidazolines; Male; Pain; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Reserpine | 2019 |
Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test.
Topics: Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HEK293 Cells; Hindlimb Suspension; Humans; Locomotion; Male; Mice; Mice, Inbred ICR; Quinazolines; Serotonin Antagonists; Xenopus laevis | 2019 |
Prodepressive effect induced by microinjections of MCH into the dorsal raphe: time course, dose dependence, effects on anxiety-related behaviors, and reversion by nortriptyline.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Central Nervous System Depressants; Cyclohexylamines; Depression; Dorsal Raphe Nucleus; Dose-Response Relationship, Drug; Hypothalamic Hormones; Male; Maze Learning; Melanins; Microinjections; Motor Activity; Neuropsychological Tests; Nortriptyline; Pituitary Hormones; Quinazolines; Rats, Wistar; Receptors, Somatostatin; Time Factors | 2014 |
Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Depression; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines | 2009 |
Drug discovery: playing dirty.
Topics: Animals; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Clozapine; Depression; Drug Approval; Drug Design; Drug Evaluation, Preclinical; Drug Industry; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Piperazines; Pyrimidines; Quinazolines; Sensitivity and Specificity; Substrate Specificity; Therapeutics; United States; United States Food and Drug Administration | 2005 |
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; Sulfonamides; Syndrome; Tamsulosin; Urinary Bladder, Overactive | 2006 |
[A clinical study with prazosin].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Benzothiadiazines; Depression; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Prazosin; Quinazolines; Sexual Behavior; Sodium Chloride Symporter Inhibitors; Urination Disorders | 1978 |